Gram-negative bacteremia and endotoxemia still cause a high risk of mortality in clinics, although new types of antibiotics have been developed and used to treat gramnegative bacterial infectious diseases. This is true especially for infections caused by Pseudomonas aeruginosa. Activation of the immune system of a host by active or passive immunization in combination with antibiotic therapy is needed to cure pseudomonal infections completely.
P. aeruginosa strains produce a number of extracellular products, including exotoxin A (17) , elastase (20) , and protease (15) , which have been reported to be involved in the pathogenesis and virulence of P. aeruginosa. Cell surface components, such as lipopolysaccharide (5) , alginate (6) , pili (19) , and flagella (14) , are also involved in the pathogenesis and virulence of this bacterium. These virulence factors may be candidates as target molecules for vaccine and passive immunization.
Flagella help bacteria to move more rapidly from colonized sites to blood vessels and promote progress from local to systemic infection. Flagella have been reported to play an important role in pseudomonal infections of burned patients in whom the immune system is temporarily suppressed by burning (16) . Furthermore, vaccination with flagellar preparations (9) and antibody therapy with antiflagellar sera (7) have been demonstrated to be protective against lethal challenges with P. aeruginosa strains bearing flagella in the experimental burned-mouse model.
Here we describe human monoclonal antibodies (MAbs) against flagella of P. aeruginosa and show that the MAbs act in a mode different from that of 0 antigen-specific MAbs and potently protect burned mice against P. aeruginosa infections. * Holder, University of Cincinnati, Cincinnati, Ohio. Clinical isolates of P. aeruginosa were stocked in our laboratory, and the 0 serotype was determined with a Meiassay serotype grouping kit (Meiji Seika Co., Tokyo, Japan). All strains were grown on heart infusion agar (Nissui Pharmaceuticals, Tokyo, Japan) at 37°C.
General methods. Methods for preparation of human mouse hybridomas, enzyme-linked immunosorbent assay (ELISA), and Western blotting (immunoblotting) analysis were exactly as previously described (21), except for the following minor modifications. Peripheral blood lymphocytes from healthy adult donors whose sera had high antibody titers against whole P. aeruginosa cells and were supposed to have been naturally exposed to P. aeruginosa at some time were stimulated in RPMI 1640 culture medium containing 0.0002% (wt/vol) Formalin-killed P. aeruginosa 1ID1002 (serotype B) cells, 0.2% (vol/vol) pokeweed mitogen, heat-inactivated fetal bovine serum, sodium pyruvate, N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid (HEPES), 2-mercaptoethanol, and antibiotics, and the stimulated peripheral blood lymphocytes were fused with mouse myeloma cell line P3X63-Ag8.653 (ATCC CRL/580). Hybridoma cell line IN-2A8 was adapted to serum-free medium (Celgrosser H; Sumitomo Pharmaceuticals, Osaka, Japan) for further studies. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) was performed by using a slab gel apparatus (Bio-Rad Laboratories, Richmond, Calif.) by the method of Laemmli (11) with a slight modification. The stacking gel contained 3% acrylamide, and the separating gel contained 10% acrylamide. Proteins in the gel and on the Durapore filter were detected by staining with Coomassie brilliant blue.
Preparation of flagellin. Flagellin was isolated by the method of Montie et al. (13) with a slight modification. P. aeruginosa cells were cultured on heart infusion agar at 37°C for 17 h. Grown cells were gently scraped from the agar surface and suspended in phosphate-buffered saline (PBS). Cell suspensions were centrifuged at 5,000 x g for 15 min at 4°C. The resulting pellet was suspended in PBS and blended in a commercial blender (Automatic Mixer S-100; Taiyokagaku, Tokyo, Japan) for 3 min to shear off the flagella. Suspension was centrifuged at 16,000 x g for 15 min at 4°C, and the resulting supernatant was centrifuged again at 40,000 x g for 3 h at 4°C. The supernatant was carefully removed, and the pellet was suspended in a small amount of PBS and used for further experiments as a preparation of flagellin. The purity of flagellin preparations was demonstrated to be about 90% by SDS-PAGE.
The burned-mouse model. Burned mice were prepared by the method of Stieritz and Holder (18) with a slight modification. Four-week-old male ICR mice were anesthetized. A glass fiber filter was dipped into ethanol, ignited, and placed over the shaved backs of the mice for 10 s. The mice were given 0.3 ml of sterile saline intraperitoneally to prevent shock caused by burning. The mice were then given 0.2 ml of a serially diluted bacterial suspension subcutaneously at the burn site. At (13) . MAb IN-2A8 specifically immunoreacted with the major band in the flagellin preparation but not with the minor band (Fig. 1, lanes 5 and 6) , indicating that MAb IN-2A8 specifically binds to flagellin.
The inhibitory activity of MAb IN-2A8 against the motility of P. aeruginosa cells was examined by measuring the rate of inhibition of colony spreading in soft agar compared with that of a specific human immunoglobulin M MAb to the 0 antigen of Homma serotype B (MAb KO-2F2), which was established in our laboratory by the human-mouse hybridoma method. MAb IN-2A8 partly inhibited the motility of P. aeruginosa Homma serotype B standard strain 1ID1002, which had low virulence in the burned-mouse model, at a concentration lower than 0.2 ,ug/ml (Fig. 2) . Both MAbs inhibited bacterial motility in a concentration-dependent manner at a concentration higher than 0.5 ,ug/ml, but MAb IN-2A8 showed relatively stronger inhibition than MAb KO-2F2. Against highly motile strain M2 (Homma serotype B), which was highly virulent in the burned-mouse model, on the other hand, more than 1 ,ug of MAb IN-2A8 per ml was required for inhibition of bacterial motility. In contrast, however, MAb KO-2F2 showed only a slight effect at a concentration of 25 p,g/ml. The inhibitory activities of MAbs against bacterial motility in soft agar should be tightly DISCUSSION associated with their bacterial agglutinating activity, because agglutinated bacteria cannot migrate rapidly in soft agar. Therefore, we examined the agglutinating activities of MAbs IN-2A8 and KO-2F2. The minimum concentrations of the MAbs required for agglutination of viable and killed bacteria are shown in Table 3 . MAb IN-2A8 at a low concentration strongly agglutinated Formalin-killed P. aeruginosa IID1002 and M2 cells, but it showed no or weak agglutinating activity against viable bacteria. MAb KO-2F2 agglutinated viable bacteria at more than 5 ,ug/ml for M2 and 0.5 ,ug/ml for IID1002.
The PMN-mediated opsonophagocytic killing activity of MAb IN-2A8 was very low (Table 4) . MAb IN-2A8 mediated bacterial killing at a rate of only 45% after incubation of bacteria at 8 x 105 CFU/ml with 1 ,ug of MAb per ml at 37°C for 2 h, while human MAb KO-2F2 to 0 antigen mediated 99.3% killing of bacteria under the same conditions. MAb IN-2A8 at 0.1 ,ug per mouse (5 ,ug/kg of body weight) showed potent protective activity in burned mice challenged with 380 and 330 LD50s of P. aeruginosa SP10052 and M2 (Homma serotype B), respectively. Administration of the MAb at 1 ,ug per mouse saved mice challenged with 104 LD50s of P. aeruginosa SP10052 from death. Although protective activity was influenced by the number of bacteria used for the challenge, the protective dose giving a 50% survival rate which was calculated 7 days after administration of a serially 10-fold-increasing dosage of MAb IN Lanyi (12) , who used antisera to determine H serotypes.
MAb IN-2A8 strongly protected burned mice challenged with P. aeruginosa bearing b-type flagella (Table 5) , independently of the 0 serotype, and the MAb effectively inhibited the motility of P. aeruginosa in soft agar (Fig. 2) . However, the MAb very slightly enhanced the ability of PMNs to kill bacteria in the presence of complement (Table  4) . A line of evidence suggests that the in vivo protective activity gf the MAb in burned mice is likely to be due mainly to binding of the MAb to flagella and resulting inhibition of bacterial motility and to be less associated with opsonophagocytic activity. In contrast, Drake and Montie and Anderson and Montie reported that antiflagellar serum was protective against lethal challenges with P. aeruginosa in the burned-mouse model (7) and had opsonophagocytic activity in vitro (1, 2) , concluding that the in vivo activity of flagellar antiserum was dependent on both its inhibitory activity against bacterial motility and its opsonophagocytic activity. report (14) showing that bacterial motility was one of the most important virulence factors in the burned-mouse system, by comparing the virulence of strain M2 with that of its nonflagellar mutant. Many investigators have reported on MAbs to the 0 antigen of P. aeruginosa. The 0-antigen-specific MAbs showed potent protective activities in vivo and enhanced opsonophagocytosis in vitro. However, these MAbs to the 0 antigen possess a narrow range of binding and protective activities. In other words, the MAbs have no activities against either strains belonging to serotypes other than a specific 0 serotype or rough strains, such as Homma serotype M (10), which seem to be important pathogens for respiratory tract infections in patients with cystic fibrosis (8) . In contrast, MAbs against flagella of P. aeruginosa bound to a wide range of strains independently of 0 serotypes, including rough strains, and inhibited bacterial motility, resulting in prevention of bacterial invasion from colonized sites to blood vessels. Thus, they might be useful for curing complicated local infections with P. aeruginosa, such as burn and respiratory tract infections.
More detailed studies on the in vivo protective activities of these MAbs are in progress.
